InspireMD
NSPR
37 hedge funds and large institutions have $15.1M invested in InspireMD in 2026 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 5 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 5
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
6% more funds holding
Funds holding: 35 → 37 (+2)
2.76% less ownership
Funds ownership: 48.72% → 45.96% (-2.8%)
59% less capital invested
Capital invested by funds: $37.2M → $15.1M (-$22.1M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Aberdeen Group
Edinburgh,
United Kingdom
|
+$557K |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
+$105K |
| 3 |
Renaissance Technologies
New York
|
+$101K |
| 4 |
Creative Planning
Overland Park,
Kansas
|
+$94.6K |
| 5 |
HF
HRT Financial
New York
|
+$63.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VCIM
Velan Capital Investment Management
Alpharetta,
Georgia
|
-$2.07M |
| 2 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$186K |
| 3 |
Millennium Management
New York
|
-$79.3K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$69.7K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$54.7K |
NSPR Hedge Fund Activity: Q2 2026 in Review
37 of the 8,305 institutional investors tracked by Wall St. Rank reported a position in InspireMD (NSPR) for Q2 2026, worth a combined $15.1M — down 59% from $37.2M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new NSPR positions and 5 closed out — a net gain of 2 holders — while 10 added to existing stakes and 5 trimmed.
The largest buyer was Aberdeen Group, adding an estimated $557K. The largest seller was Velan Capital Investment Management, cutting an estimated $2.07M.
- 37 institutional investors held InspireMD (NSPR) as of Q2 2026, up from 35 in Q1 2026.
- Funds reported $15.1M of InspireMD stock for Q2 2026, down 59% quarter-over-quarter.
- 7 funds opened new InspireMD positions in Q2 2026 and 5 closed out, a net change of +2 holders.
- The largest InspireMD buyer in Q2 2026 was Aberdeen Group, an estimated $557K added.
- The largest InspireMD seller in Q2 2026 was Velan Capital Investment Management, an estimated $2.07M sold.
Based on aggregated 13F filings for Q2 2026.